Earlier this week, Biogen and ViGeneron signed a global collaboration and licensing agreement to develop gene therapies for inherited eye
Continue Reading Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development

To learn about Ms. Wilmot's practice, please visit: https://www.rothwellfigg.com/professionals/cwilmot.
Earlier this week, Biogen and ViGeneron signed a global collaboration and licensing agreement to develop gene therapies for inherited eye…
Continue Reading Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
Founders of technology-based companies often recognize very early on that their company’s IP and related technology comprise a significant or…
Continue Reading Emerging Companies: Framework for Leveraging Your IP & Tech
With the EU’s 2018 General Data Protection Regulation (GDPR), the California Consumer Privacy Act (CCPA), which became effective January 2020,…
Continue Reading Keeping Privacy in Mind in the Early Stages of Your Company
We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.